Tuesday, February 24, 2026
News Health
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health
No Result
View All Result
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health
No Result
View All Result
HealthNews
No Result
View All Result
Home Health News

Sleep Apnea Measure Predicts Complications After Major Surgery

February 24, 2026
in Health News
Share on FacebookShare on Twitter



  • The sleep apnea-specific hypoxic burden metric correlated with 30-day postoperative mortality and cardiovascular complications among obstructive sleep apnea (OSA) patients undergoing major noncardiothoracic surgery.
  • This measure describes both the frequency of upper airway obstructions as well as the duration and depth of oxygen desaturations during sleep.
  • The study couldn’t determine clinical impact of using the score in place of other measures of OSA severity in the noncardiothoracic surgery setting, although it may have greater utility.

A metric for obstructive sleep apnea (OSA) that accounts for oxygen desaturation along with frequency of obstruction correlated with hard outcomes among patients undergoing major noncardiothoracic surgery, a study showed.

The rate of 30-day postoperative mortality and cardiovascular complications increased significantly from 1.6% in patients with a low sleep apnea-specific hypoxic burden (SASHB; less than 32% min/h) to 5.8% among those with a high SASHB (at least 80% min/h) at diagnosis, Sébastien Bailly, PharmD, PhD, of University Grenoble Alpes in France, and colleagues reported in JAMA Network Open.

Risk climbed with SASHB, with odds ratios of 1.76 for those with 32-80% min/h and 2.79 at over 80% min/h as compared with less than 32% min/h.

This measure, defined by the area under the desaturation curve associated with sleep-related obstructive respiratory events, describes both the frequency of upper airway obstructions as well as the duration and depth of oxygen desaturations during sleep.

The typical measure of OSA severity — apnea-hypopnea index — doesn’t adequately capture risk, Bailly’s group argued, with prior studies showing a stronger association of SASHB with cardiovascular adverse events.

The finding that SASHB is independently associated with risk in postoperative settings is consistent with data from nonsurgical settings, the researchers said.

The anatomical and physiological factors that lead to OSA also “increase vulnerability to airway obstruction under general anesthetics, sedatives, and postoperative analgesics that relax the upper airway muscles and impair ventilatory response,” potentially predisposing OSA patients to postoperative mortality complications, the group noted.

“Further research is needed to determine whether interventions guided by SASHB scores can modify postoperative risk in patients with OSA,” they wrote.

The study didn’t compare outcomes between patients prospectively managed according to one risk tool versus another. However, SASHB did look promising to improve estimation of risk of postoperative complications, according to the researchers.

A risk score based on age, emergency admission before surgery, and SASHB had an area under receiver operating characteristic curve of 0.73 (95% CI 0.68-0.77). A simplified, and more accessible, version of SASHB automatically derived from the single oximetry signal extracted from diagnostic sleep studies performed similarly (0.75, 95% CI 0.67-0.78).

An elastic net regression analysis comparing performance of those two versions against the apnea-hypopnea index and other conventional measures of OSA severity showed that the SASHB had stronger associations with the primary outcome of 30-day mortality or cardiovascular complications.

The negative predictive value of the full risk score was high at 96% or more, as postoperative complications were rare in the cohort studied, Bailly and colleagues noted. “This finding suggests that the score performs best as a rule-out tool, which might be clinically useful for identifying individuals who may safely undergo standard postoperative monitoring, thereby helping to prioritize resources for higher-risk patients.”

The study included 2,286 adult OSA patients (median age 58, 64.4% men) who were treated at healthcare clinics participating in the Pays de la Loire Sleep Cohort and underwent major noncardiothoracic surgery between OSA diagnosis and December 2024, a median of 4.5 years after OSA diagnosis.

The participants were followed for outcomes using a French health administrative database. Altogether, 80 patients (3.5%) had a primary endpoint within 30 days of surgery, encompassing stroke, atrial fibrillation, heart failure, myocardial infarction, venous thromboembolism, and all-cause mortality.

Findings were similar across demographics, history of cardiovascular diseases, type of sleep study, delay between OSA diagnosis and surgery, and use of positive airway pressure (PAP) therapy.

Limitations included reliance on administrative health databases for outcomes, potential for residual confounding from unmeasured factors (which included opioid or oral morphine equivalents usage and use of PAP in the recovery room and postoperative period), and inability to determine causality.

“Further studies are required to define a specific actionable SASHB threshold for perioperative PAP protocols and enhanced monitoring,” the researchers noted.



Source link : https://www.medpagetoday.com/pulmonology/sleepdisorders/120016

Author :

Publish date : 2026-02-24 16:33:00

Copyright for syndicated content belongs to the linked Source.

Previous Post

RFK Jr. Fought Pesticides for Years. Now He’s Backing Their Production.

Next Post

What to Know About Chronic Cough in Patients Taking GLP-1s

Related Posts

Health News

What to Know About Chronic Cough in Patients Taking GLP-1s

February 24, 2026
Health News

RFK Jr. Fought Pesticides for Years. Now He’s Backing Their Production.

February 24, 2026
Health News

CDC Official Quits; Experts Fear Polio Comeback; Frozen Meatball Recall

February 24, 2026
Health News

Brief Program Improves QoL in Patients With Severe Allergies

February 24, 2026
Health News

Rise of NPs Leads to More Advanced Certifications

February 24, 2026
Health News

Ruxolitinib: Landmark vitiligo cream targets immune cells that disrupt pigmentation

February 24, 2026
Load More

What to Know About Chronic Cough in Patients Taking GLP-1s

February 24, 2026

Sleep Apnea Measure Predicts Complications After Major Surgery

February 24, 2026

RFK Jr. Fought Pesticides for Years. Now He’s Backing Their Production.

February 24, 2026

CDC Official Quits; Experts Fear Polio Comeback; Frozen Meatball Recall

February 24, 2026

Brief Program Improves QoL in Patients With Severe Allergies

February 24, 2026

Rise of NPs Leads to More Advanced Certifications

February 24, 2026

Ruxolitinib: Landmark vitiligo cream targets immune cells that disrupt pigmentation

February 24, 2026

New NHS Option for Relapsed Follicular Lymphoma

February 24, 2026
Load More

Categories

Archives

February 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
232425262728  
« Jan    

© 2022 NewsHealth.

No Result
View All Result
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health

© 2022 NewsHealth.

Go to mobile version